The Chilean government has awarded a contract to Chinese biopharmaceutical firm Sinovac Biotech to supply its influenza vaccine ahead of the southern hemisphere winter.
The vaccine will be part of Chile’s nationwide immunisation programme, which public health body Cenabast said was “internationally recognised for its impact on public health protection, particularly among high-risk groups”.
Beijing-based Sinovac’s influenza vaccine uses an inactivated virus based on a split-virion platform – a…
Chinese firm Sinovac to supply vaccine to Chile ahead of flu season
